These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 32420685)

  • 1. Long non-coding RNA SNGH7 Is activated by SP1 and exerts oncogenic properties by interacting with EZH2 in ovarian cancer.
    Bai Z; Wu Y; Bai S; Yan Y; Kang H; Ma W; Zhang J; Gao Y; Hui B; Ma H; Li R; Zhang X; Ren J
    J Cell Mol Med; 2020 Jul; 24(13):7479-7489. PubMed ID: 32420685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA ATB promotes ovarian cancer tumorigenesis by mediating histone H3 lysine 27 trimethylation through binding to EZH2.
    Chen XJ; An N
    J Cell Mol Med; 2021 Jan; 25(1):37-46. PubMed ID: 33336896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Noncoding RNA LINC00673 Is Activated by SP1 and Exerts Oncogenic Properties by Interacting with LSD1 and EZH2 in Gastric Cancer.
    Huang M; Hou J; Wang Y; Xie M; Wei C; Nie F; Wang Z; Sun M
    Mol Ther; 2017 Apr; 25(4):1014-1026. PubMed ID: 28214253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma.
    Xu Y; Yao Y; Jiang X; Zhong X; Wang Z; Li C; Kang P; Leng K; Ji D; Li Z; Huang L; Qin W; Cui Y
    J Exp Clin Cancer Res; 2018 Apr; 37(1):81. PubMed ID: 29642935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Sp1/FOXC1/HOTTIP/LATS2/YAP/β-catenin cascade promotes malignant and metastatic progression of osteosarcoma.
    Liu K; Ni JD; Li WZ; Pan BQ; Yang YT; Xia Q; Huang J
    Mol Oncol; 2020 Oct; 14(10):2678-2695. PubMed ID: 32634265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC01210 accelerates proliferation, invasion and migration in ovarian cancer through epigenetically downregulating KLF4.
    Zhang C; Liu J; Zhang Y; Luo C; Zhu T; Zhang R; Yao R
    Biomed Pharmacother; 2019 Nov; 119():109431. PubMed ID: 31514068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer.
    Ma Z; Peng P; Zhou J; Hui B; Ji H; Wang J; Wang K
    Cell Physiol Biochem; 2018; 46(6):2197-2214. PubMed ID: 29734178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA SNHG1 promotes bladder cancer progression by upregulating EZH2 and repressing KLF2 transcription.
    Min J; Ma J; Wang Q; Yu D
    Clinics (Sao Paulo); 2022; 77():100081. PubMed ID: 36087568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
    Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
    Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long non-coding RNA SNHG1 promotes bladder cancer progression by interacting with miR-143-3p and EZH2.
    Xiang W; Lyu L; Huang T; Zheng F; Yuan J; Zhang C; Jiang G
    J Cell Mol Med; 2020 Oct; 24(20):11858-11873. PubMed ID: 32885590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long non-coding RNA DANCR regulates the inflammatory phenotype of breast cancer cells and promotes breast cancer progression via EZH2-dependent suppression of SOCS3 transcription.
    Zhang KJ; Tan XL; Guo L
    Mol Oncol; 2020 Feb; 14(2):309-328. PubMed ID: 31860165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC00702 accelerates the progression of ovarian cancer through interacting with EZH2 to inhibit the transcription of KLF2.
    Wang L; Ye TY; Wu H; Chen SY; Weng JR; Xi XW
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):201-208. PubMed ID: 31389610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC01232 Promotes Gastric Cancer Proliferation through Interacting with EZH2 to Inhibit the Transcription of KLF2.
    Liu J; Li Z; Yu G; Wang T; Qu G; Wang Y
    J Microbiol Biotechnol; 2021 Oct; 31(10):1358-1365. PubMed ID: 34409953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.
    Wu D; He X; Wang W; Hu X; Wang K; Wang M
    Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.
    Yang X; Sun L; Wang L; Yao B; Mo H; Yang W
    Biomed Pharmacother; 2019 Oct; 118():109386. PubMed ID: 31545291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression.
    Fang J; Sun CC; Gong C
    Biochem Biophys Res Commun; 2016 Sep; 478(2):811-7. PubMed ID: 27501756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Noncoding RNA
    Chi C; Li M; Hou W; Chen Y; Zhang Y; Chen J
    Cancer Biother Radiopharm; 2020 Jun; 35(5):329-337. PubMed ID: 32275170
    [No Abstract]   [Full Text] [Related]  

  • 20. Long non-coding RNA LINC01133 represses KLF2, P21 and E-cadherin transcription through binding with EZH2, LSD1 in non small cell lung cancer.
    Zang C; Nie FQ; Wang Q; Sun M; Li W; He J; Zhang M; Lu KH
    Oncotarget; 2016 Mar; 7(10):11696-707. PubMed ID: 26840083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.